10 August 2021 - Enthusiasm for the use of outcomes based managed entry agreements to manage uncertainties apparent at the time ...
14 May 2021 - The desire, opportunity, and willingness to increase access to potentially life saving cancer treatments has mounted in ...
29 January 2021 - Managed entry agreements are increasingly used to address uncertainties arising in the health technology assessment process due ...
10 October 2020 - Managed entry agreements consist of a set of instruments to reduce the uncertainty and the budget impact ...
6 July 2020 - Managed entry agreements have been used for several years, with the aim of curbing the growth of ...
21 April 2020 - This article begins with a short review of the existing taxonomy of managed entry agreements and includes ...
3 January 2019 - Managed entry agreements enable payers to subsidise access to new medicines while addressing uncertainties. ...
31 May 2018 - Innovative pricing agreements for medicines have been used in European markets for more than 20 years, ...
23 April 2018 - In 2010, the Australian Government introduced the managed entry scheme (MES) to improve patient access to subsidised ...
12 January 2018 - The changing regulatory landscape brings new challenges to health technology assessment. Marketing authorisations are being granted as ...
26 December 2017 - Australia relies on managed entry agreements for many medicines added to the national Pharmaceutical Benefits Scheme. ...
8 September 2016 - The communiques from the February 2015, September 2015 and April 2016 meetings of the Access to Medicines ...
29 February 2016 - NHS England has confirmed that from 1 July its Cancer Drugs Fund will operate on a “managed ...